These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1794005)

  • 1. Is ganglioside GM1 effective in the treatment of stroke?
    Braune S
    Drugs Aging; 1991 Jan; 1(1):57-66. PubMed ID: 1794005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of GM1 ganglioside in cerebrovascular diseases: a double-blind trial in 40 cases.
    Battistin L; Cesari A; Galligioni F; Marin G; Massarotti M; Paccagnella D; Pellegrini A; Testa G; Tonin P
    Eur Neurol; 1985; 24(5):343-51. PubMed ID: 3902480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM1 ganglioside therapy in acute ischemic stroke. Italian Acute Stroke Study--Hemodilution + Drug.
    Argentino C; Sacchetti ML; Toni D; Savoini G; D'Arcangelo E; Erminio F; Federico F; Milone FF; Gallai V; Gambi D
    Stroke; 1989 Sep; 20(9):1143-9. PubMed ID: 2672425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganglioside GM1 in acute ischemic stroke. The SASS Trial.
    Stroke; 1994 Jun; 25(6):1141-8. PubMed ID: 8202971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating neuroprotective agents for clinical anti-ischemic benefit using neurological and neuropsychological changes after cardiac surgery under cardiopulmonary bypass. Methodological strategies and results of a double-blind, placebo-controlled trial of GM1 ganglioside.
    Grieco G; d'Hollosy M; Culliford AT; Jonas S
    Stroke; 1996 May; 27(5):858-74. PubMed ID: 8623106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind evaluation of monosialoganglioside (GM1) therapy in stroke.
    Bassi S; Albizzati MG; Sbacchi M; Frattola L; Massarotti M
    J Neurosci Res; 1984; 12(2-3):493-8. PubMed ID: 6389896
    [No Abstract]   [Full Text] [Related]  

  • 7. Trial of ganglioside GM1 in acute stroke.
    Appollonio I; Frattola L; Massarotti M
    J Neurol Neurosurg Psychiatry; 1989 May; 52(5):685-6. PubMed ID: 2732750
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review.
    Zhang W; Krafft PR; Wang T; Zhang JH; Li L; Tang J
    Cell Transplant; 2019 Jun; 28(6):657-661. PubMed ID: 30666888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GM1 ganglioside therapy in acute ischemic stroke.
    Oppenheimer S
    Stroke; 1990 May; 21(5):825. PubMed ID: 2339464
    [No Abstract]   [Full Text] [Related]  

  • 10. GM1 ganglioside treatment of Parkinson's disease: an open pilot study of safety and efficacy.
    Schneider JS; Roeltgen DP; Rothblat DS; Chapas-Crilly J; Seraydarian L; Rao J
    Neurology; 1995 Jun; 45(6):1149-54. PubMed ID: 7783880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in tardive dyskinesia symptoms in elderly patients treated with ganglioside GM1 or placebo.
    Sommer BR; Cohen BM; Satlin A; Cole JO; Jandorf L; Dorsey F
    J Geriatr Psychiatry Neurol; 1994; 7(4):234-7. PubMed ID: 7826493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early treatment of stroke with monosialoganglioside GM-1. Efficacy and safety results of the Early Stroke Trial.
    Lenzi GL; Grigoletto F; Gent M; Roberts RS; Walker MD; Easton JD; Carolei A; Dorsey FC; Rocca WA; Bruno R
    Stroke; 1994 Aug; 25(8):1552-8. PubMed ID: 8042206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GM1 ganglioside treatment of spontaneously hypertensive stroke prone rats.
    Hernandez NE; MacDonall JS; Stier CT; Belmonte A; Fernandez R; Karpiak SE
    Exp Neurol; 1994 Mar; 126(1):95-100. PubMed ID: 8157130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.
    Schneider JS
    J Neurosci Res; 1992 Jan; 31(1):112-9. PubMed ID: 1613817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ganglioside GM1 in early strokes].
    Kuczyńska-Zardzewiały A; Kruszewska J; Lechowicz W; Członkowska A
    Neurol Neurochir Pol; 1994; 28(5):643-9. PubMed ID: 7862232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gangliosides--a new therapeutic agent against stroke and Alzheimer's disease.
    Svennerholm L
    Life Sci; 1994; 55(25-26):2125-34. PubMed ID: 7997071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM1 ganglioside in the treatment of Parkinson's disease.
    Schneider JS
    Ann N Y Acad Sci; 1998 Jun; 845():363-73. PubMed ID: 9668369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monosialoganglioside therapy in stroke.
    Bassi S; Albizzati MG; Sbacchi M; Frattola L; Massarotti M
    Stroke; 1985; 16(5):899-900. PubMed ID: 3901426
    [No Abstract]   [Full Text] [Related]  

  • 19. Design and baseline results of the monosialoganglioside early stroke trial. The EST Study Group.
    Rocca WA; Dorsey FC; Grigoletto F; Gent M; Roberts RS; Walker MD; Easton JD; Bruno R; Carolei A; Sancesario G
    Stroke; 1992 Apr; 23(4):519-26. PubMed ID: 1561683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM1 ganglioside in Parkinson's disease: Results of a five year open study.
    Schneider JS; Sendek S; Daskalakis C; Cambi F
    J Neurol Sci; 2010 May; 292(1-2):45-51. PubMed ID: 20206941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.